Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 318 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact318 DOIs

Add abstracts to 35 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact35 DOIs

Deposit reference lists for 21 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact21 DOIs

DOIs for this ISSN

Showing the top 5 of 691 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	An introduction to the epidemiology and burden of urinary tr… (10.1177/1756287219832172)	ORCID	71.24	706
2	Risk factors and predisposing conditions for urinary tract… (10.1177/1756287218814382)	ORCID	57.31	195
3	Management of iatrogenic ureteral injury (10.1177/1756287214526767)	ORCID	57.14	192
4	Role of inflammation in bladder function and interstitial cy… (10.1177/1756287211398255)	ORCID	56.80	186
5	The Prostate Health Index: a new test for the detection of p… (10.1177/1756287213513488)	ORCID	55.76	169
6	Management of inferior vena cava tumor thrombus in locally a… (10.1177/1756287215576443)	ORCID	53.81	141
7	Oxidation-reduction potential of semen: what is its role in… (10.1177/1756287216652779)	ORCID	52.85	129
8	Contemporary diagnosis and management of Fournier’s gangrene (10.1177/1756287215584740)	ORCID	52.76	128
9	Best practice in the treatment of nonmuscle invasive bladder… (10.1177/1756287211431976)	ORCID	52.42	124
10	Mirabegron: a review of recent data and its prospects in the… (10.1177/1756287212457114)	ORCID	51.52	114
11	The link between vascular dysfunction, bladder ischemia, and… (10.1177/1756287216675778)	ORCID	51.52	114
12	Testosterone and prostate cancer: an evidence-based review o… (10.1177/1756287215597633)	ORCID	51.13	110
13	Targeting PD-1/PD-L1 in the treatment of metastatic renal ce… (10.1177/1756287215597647)	ORCID	50.32	102
14	Biomarkers in prostate cancer surveillance and screening: pa… (10.1177/1756287213495915)	ORCID	50.00	99
15	‘Mini, ultra, micro’ – nomenclature and cost of these new mi… (10.1177/1756287215617674)	ORCID	49.09	91
16	Dapoxetine: a new option in the medical management of premat… (10.1177/1756287212453866)	ORCID	48.98	90
17	Testosterone deficiency in the aging male (10.1177/1756287215612961)	ORCID	48.98	90
18	Ureteral stents: new ideas, new designs (10.1177/1756287210370699)	ORCID	48.49	86
19	Shockwave treatment of erectile dysfunction (10.1177/1756287212470696)	ORCID	48.36	85
20	Management of priapism: an update for clinicians (10.1177/1756287214542096)	ORCID	47.58	79
21	The increasing pediatric stone disease problem (10.1177/1756287211400491)	ORCID	46.58	72
22	Malignancy after gastrointestinal augmentation in childhood (10.1177/1756287209104163)	ORCID	46.28	70
23	Management of spermatic cord tumors: a rare urologic maligna… (10.1177/1756287212447839)	ORCID	46.13	69
24	The efficacy and safety of mirabegron compared with solifena… (10.1177/1756287215589250)	ORCID	45.97	68
25	Is suction the future of endourology? Overview from EAU Sect… (10.1177/17562872241232275)	Abstract	45.97	68
26	Androgen deprivation therapy and cardiovascular disease: wha… (10.1177/1756287215617872)	ORCID	45.81	67
27	Sunitinib in the treatment of metastatic renal cell carcinom… (10.1177/1756287216663979)	ORCID	45.65	66
28	Recent developments in the treatment of renal cell carcinoma (10.1177/1756287213505672)	ORCID	45.49	65
29	The role of neoadjuvant therapy in the management of locally… (10.1177/1756287215612962)	ORCID	44.98	62
30	Sunitinib in the treatment of renal cell carcinoma: an updat… (10.1177/1756287217713902)	ORCID	44.98	62
31	The role of the gubernaculum in the descent and undescent of… (10.1177/1756287209105266)	ORCID	43.90	56
32	Abiraterone and other novel androgen-directed strategies for… (10.1177/1756287212452196)	ORCID	43.90	56
33	The evolution of lasers in urology (10.1177/1756287211400494)	ORCID	43.70	55
34	The potential role of stem cells in the treatment of urinary… (10.1177/1756287214553968)	ORCID	43.70	55
35	Chronic orchialgia: evaluation and discussion of treatment o… (10.1177/1756287210390409)	ORCID	43.51	54
36	Management of carcinoma <i>in situ</i> of the bladder: best… (10.1177/1756287215599694)	ORCID	43.51	54
37	Histone deacetylase inhibitors in castration-resistant prost… (10.1177/1756287215597637)	ORCID	43.31	53
38	An update on enzalutamide in the treatment of prostate cance… (10.1177/1756287214555336)	ORCID	43.11	52
39	Use of intravesical valrubicin in clinical practice for trea… (10.1177/1756287214541798)	ORCID	42.47	49
40	An update on the use of gonadotropin-releasing hormone antag… (10.1177/1756287211414457)	ORCID	42.25	48
41	Retroperitoneal lymphadenectomy and resection for testicular… (10.1177/1756287212443170)	ORCID	42.25	48
42	Electrical neuromodulation in the management of lower urinar… (10.1177/1756287218756082)	ORCID	42.25	48
43	Current approach to the treatment of penile implant infectio… (10.1177/1756287210370330)	ORCID	42.03	47
44	The role of cabazitaxel in the treatment of metastatic castr… (10.1177/1756287214528557)	ORCID	42.03	47
45	Diagnosis and management of premalignant penile lesions (10.1177/1756287211412657)	ORCID	41.80	46
46	Experience with degarelix in the treatment of prostate cance… (10.1177/1756287212461048)	ORCID	41.80	46
47	Primary Ewing sarcoma of the kidney: a symptomatic presentat… (10.1177/1756287212471095)	ORCID	41.80	46
48	Optimal treatment of tuberous sclerosis complex associated r… (10.1177/1756287216641353)	ORCID	41.80	46
49	Best practice in the management of storage symptoms in male… (10.1177/1756287217742837)	ORCID	41.80	46
50	Evidence for the efficacy of enzalutamide in postchemotherap… (10.1177/1756287213490054)	ORCID	41.57	45